Shots: CEPI to provide $4.4M to Novavax & the University of Oxford for accelerating the development of vaccines against COVID-19. CEPI has invested up to $23.7M in R&D of COVID-19 […]readmore
Tags : vaccine
Shots: The collaboration supports the development of vaccines leveraging Heat’s gp96 platform designed to target SARS-CoV-2 coronavirus causing COVID-19 Heat’s subsidiary Zolovax will focus on the development of COVID-19 vaccines […]readmore
Shots: The US NIH to provide vaccine candidates and related material to Medigen Vaccine Biologic (MVC) to initiate the preclinical development of a vaccine for Covid-19 in Taiwan The results […]readmore
Shots: Codagenix will utilize its deoptimization technology for viral deoptimization, designed several nCoV vaccine candidate genomes, will grow and conduct in-vivo tests of vaccine viruses prior to testing in clinical […]readmore
Shots: GSK will utilize its adjuvant platform technology for developing a vaccine against the 2019-nCoV virus. The use of adjuvant technology lead to the production of more vaccine, thus increasing […]readmore
Shots: Inovio is currently evaluating INO-4800 vaccine in P-I study assessing its safety and immunogenicity in the US and is supported by a grant of ~$9M from the Coalition for […]readmore
Shots: The approval is based on the study conducted in Guinea during the 2014-2016 outbreak in individuals 18 years of age and older evaluated 3,537 contacts with laboratory-confirmed EVD who […]readmore
Shots: Pfizer is planning to pay $120M upfront along with $305M milestone payment BioNTech will also receive double-digit royalties post sales whereas, Pfizer acquires small stakes in BioNTech as part […]readmore